Charles Schwab’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-199,901
Closed -$130K 3572
2025
Q1
$130K Sell
199,901
-52,094
-21% -$33.9K ﹤0.01% 3307
2024
Q4
$464K Hold
251,995
﹤0.01% 3161
2024
Q3
$872K Buy
251,995
+35,167
+16% +$122K ﹤0.01% 2958
2024
Q2
$635K Buy
216,828
+55,952
+35% +$164K ﹤0.01% 3094
2024
Q1
$909K Hold
160,876
﹤0.01% 2819
2023
Q4
$690K Hold
160,876
﹤0.01% 2958
2023
Q3
$558K Hold
160,876
﹤0.01% 3006
2023
Q2
$748K Buy
160,876
+14,936
+10% +$69.5K ﹤0.01% 2871
2023
Q1
$674K Buy
145,940
+1,793
+1% +$8.28K ﹤0.01% 2854
2022
Q4
$1.16M Buy
144,147
+12,942
+10% +$105K ﹤0.01% 2727
2022
Q3
$729K Buy
131,205
+11,422
+10% +$63.5K ﹤0.01% 2892
2022
Q2
$625K Buy
119,783
+116
+0.1% +$605 ﹤0.01% 2981
2022
Q1
$984K Buy
119,667
+10,118
+9% +$83.2K ﹤0.01% 2854
2021
Q4
$1.63M Buy
109,549
+1,676
+2% +$25K ﹤0.01% 2765
2021
Q3
$2.04M Buy
107,873
+3,875
+4% +$73.2K ﹤0.01% 2700
2021
Q2
$1.93M Buy
103,998
+22,600
+28% +$420K ﹤0.01% 2723
2021
Q1
$1.85M Buy
81,398
+11,173
+16% +$254K ﹤0.01% 2684
2020
Q4
$1.53M Buy
70,225
+4,366
+7% +$94.8K ﹤0.01% 2675
2020
Q3
$662K Buy
65,859
+17,628
+37% +$177K ﹤0.01% 2801
2020
Q2
$375K Buy
48,231
+25,639
+113% +$199K ﹤0.01% 2948
2020
Q1
$231K Hold
22,592
﹤0.01% 2970
2019
Q4
$249K Hold
22,592
﹤0.01% 3010
2019
Q3
$206K Hold
22,592
﹤0.01% 3037
2019
Q2
$258K Buy
22,592
+9,482
+72% +$108K ﹤0.01% 3052
2019
Q1
$150K Hold
13,110
﹤0.01% 3060
2018
Q4
$119K Buy
+13,110
New +$119K ﹤0.01% 3079